Evidera's WAVE™ Model for COVID-19

Evidera's WAVE™ Model for COVID-19

Contract Research

Information

Rapid and efficient development of vaccines for SARS-COV-2 and treatments for COVID-19 requires locating sites with sufficient case loads, at the right time. The COVID-19 pandemic has also challenged unrelated trials, which are seeing attrition, missing data, and having difficulties maintaining sites and recruiting patients. The WAVE (Weekly Assessment of coVid Epidemiology) simulator models the trajectory of COVID-19 and consists of three modules to address a wide range of potential uses.
PPDBuilding upon three decades of bioanalytical expertise to support vaccine development through every phase of development, PPD's vaccine sciences lab is dedicated to helping customers achieve the highest scientific standards for their programs and gain development efficiencies that speed the introduction of life-changing vaccines.  PPD offers a full range of services across a wide variety of vaccines from legacy childhood diseases and seasonal flu to endemic pathogens and novel therapeutic vaccines PPD is a leading global contract research organization providing comprehensive, integrated drug development, vaccines, laboratory  and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and more than 24,500 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development to deliver life-changing therapies that improve health.

Log in